Health ❯ Healthcare

Neurodegenerative Diseases

Alzheimer's Disease Dementia Parkinson's Disease Cognitive Impairment Alzheimer's Research Clinical Trials Lewy Body Syndrome Research Innovations Drug Development Mucopolysaccharidosis

Blood Tests Map Decades-Long Alzheimer’s Changes and Point to Earlier Screening

New cohort analyses show blood biomarkers and self-reported memory concerns could help find people at higher risk before clinical symptoms appear.

Handwriting on Tablets Signals Cognitive Impairment in Care-Home Study

MIT Team Coaxes Chaotic Fiber Laser Into ‘Pencil Beam’ for Fast 3D Brain-Barrier Imaging

FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy Application

Finger‑Prick Alzheimer’s Blood Test Moves Forward in International Trial With 883 Enrolled

Novartis Licenses SciNeuro’s Brain‑Shuttle Alzheimer’s Antibodies in Deal Worth Up to $1.7 Billion

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

First Noninvasive MRI Maps Brain’s Tiniest Vessel Pulses, Tying Aging and Hypertension to Deep White Matter

Eye and Blood Levels of SLIT2 Track Cognition in Middle-Aged Adults, Study Finds

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Jackie Bezos, Amazon Founder’s Mother, Dies at 78

Novel Alzheimer’s Antibody Moves to Phase III After 90% Plaque Clearance

Alzheimer’s Biomarkers Emerge in Middle Age With Maternal and Kidney Associations

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Dr Khan Flags Mid-Life Hearing Loss as Largest Preventable Dementia Risk

FDA Approves First Eye Implant to Preserve Vision in Rare Macular Telangiectasia

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

Nanotherapy Using Sugar-Coated Fibers Shows Promise in Combating Alzheimer’s and ALS